Power Law company profile

Acceleron Pharma

Biotech & Life Sciences · Cambridge, United States · Founded 2004 · IPO 2013 Decacorn

Biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics

Valuation

$11B

Market cap · 2026

Revenue

$201M

Latest reported FY

Featured in Decacorn$10B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

10 investors on Acceleron Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Sutter Hill Ventures

Series B+ 9 investors entered at this stage

OrbiMed

Polaris Partners

Advanced Technology Ventures

Bessemer Venture Partners

Foresite Capital

Venrock

Flagship Pioneering

Celgene

MPM BioImpact

Global footprint

Where Acceleron Pharma has talent and traffic

Workforce by country

🇺🇸 United States · Cambridge HQ

Book a demo for the full country breakdown

Web traffic by country

50 monthly visits
across markets

🇺🇸 United States0%

Top 1 markets shown

Patent intelligence

$309M patent portfolio · 108 active families

Estimated portfolio value

$309M

2.8% of market cap · 34.3× the top peer Transcenta ($9M)

108 active patent families

Where Acceleron Pharma innovates AntagonistDiseaseMolecular biologyPharmacologyCell biology

Where Acceleron Pharma concentrates vs peers

Each axis is a top-10 topic across Acceleron Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Acceleron Pharma

An AI-synthesized read of the highest-engagement posts about Acceleron Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acceleron Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles